Edwards Lifesciences has retired 16.4% of its shares since 2011, from 689,883,180 to 576,400,000.
| Fiscal year | Date | Shares outstanding | Filing | |
|---|---|---|---|---|
| 2011 | 2012-01-31 | 689,883,180 | 10-K | |
| 2012 | 2013-01-31 | 684,603,948 | 10-K | |
| 2013 | 2014-01-31 | 643,443,282 | 10-K | |
| 2014 | 2015-01-31 | 647,039,508 | 10-K | |
| 2015 | 2016-01-31 | 643,792,782 | 10-K | |
| 2016 | 2017-01-31 | 637,487,394 | 10-K | |
| 2017 | 2018-01-31 | 630,071,124 | 10-K | |
| 2018 | 2019-01-31 | 623,298,987 | 10-K | |
| 2019 | 2020-01-31 | 627,367,734 | 10-K | |
| 2020 | 2021-01-31 | 624,518,873 | 10-K | |
| 2021 | 2022-01-31 | 623,207,437 | 10-K | |
| 2022 | 2023-01-31 | 608,313,396 | 10-K | |
| 2023 | 2024-01-31 | 601,300,000 | 10-K | |
| 2024 | 2025-01-31 | 587,900,000 | 10-K | |
| 2025 | 2026-01-31 | 580,800,000 | 10-K |
Source: all 10-K filings of Edwards Lifesciences on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.
Loading the chart from TradingView…
All-time chart by TradingView. Open it on TradingView →
Yes. Edwards Lifesciences has 0.7% fewer shares outstanding than twelve months ago, 576,400,000 as of July 31, 2026. Over five years the share count is down 7.7%.
Net of every new share it issued, Edwards Lifesciences has 113.5 million fewer shares than at its 2011 peak. That is 16.4% of the company.
576,400,000 shares, as of July 31, 2026, from the cover page of its latest 10-Q. At the 2011 peak it had 689,883,180.
Each share is a bigger slice of the company. Someone who held Edwards Lifesciences stock in 2011 owns 1.2 times as much of the business today without buying another share. Whether that was a good use of cash depends on the price paid.
Edwards Lifesciences ranks No. 231 of 251 companies on Buyback Radar by share of the company retired since its peak. Close to it on the list: Church & Dwight (16.8%), NOV (16.8%), Molina Healthcare (16.4%), Fossil Group (16.3%).
Every answer is computed from Edwards Lifesciences' own SEC filings and rebuilt every Monday. Latest count: 10-Q on EDGAR.
From the latest 13F filings. All superinvestors.
The numbers say what happened. The story says whether it can continue. We cover companies like Edwards Lifesciences in depth on Cannibal Stocks.
Read Cannibal Stocks